Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kenestrin Gel is an over-the-counter topical therapeutic gel developed by Easton Pharmaceuticals for symptomatic treatment in the multi‑billion‑dollar rheumatoid arthritis market, formulated as an odourless and colorless transdermal product intended to deliver active agents through the skin to affected joints.[2][10][16] Publicly available information emphasizes its proprietary gel delivery system and positioning as a non‑prescription product for arthritis-related pain and inflammation, but specific active pharmaceutical ingredients, molecular targets, and detailed clinical data have not been disclosed.[2][10][16]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kenestrin Gel.